{"organizations": [], "uuid": "5164890abf6c88c05838429a0f3b199a9e795b5d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/9", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/04/02/business-wire-alzheon-launches-roadshow-for-initial-public-offering.html", "country": "US", "domain_rank": 767, "title": "Alzheon Launches Roadshow for Initial Public Offering", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.005, "site_type": "news", "published": "2018-04-02T15:30:00.000+03:00", "replies_count": 0, "uuid": "5164890abf6c88c05838429a0f3b199a9e795b5d"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/04/02/business-wire-alzheon-launches-roadshow-for-initial-public-offering.html", "ord_in_thread": 0, "title": "Alzheon Launches Roadshow for Initial Public Offering", "locations": [], "entities": {"persons": [], "locations": [{"name": "framingham", "sentiment": "none"}, {"name": "mass.", "sentiment": "none"}, {"name": "edgewood", "sentiment": "none"}, {"name": "long island avenue", "sentiment": "none"}, {"name": "ny", "sentiment": "none"}], "organizations": [{"name": "alzheon, inc.", "sentiment": "neutral"}, {"name": "canaccord genuity llc", "sentiment": "none"}, {"name": "citigroup global markets inc.", "sentiment": "none"}, {"name": "broadridge financial solutions", "sentiment": "none"}, {"name": "jmp securities llc", "sentiment": "none"}, {"name": "piper jaffray & co.", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "FRAMINGHAM, Mass.--(BUSINESS WIRE)-- Alzheon, Inc. (“Alzheon”) announced today that it has launched the roadshow for the initial public offering of its common stock. Alzheon is offering 5,000,000 shares of its common stock at an initial public offering price between $13.00 and $15.00 per share. Alzheon expects to grant the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock at the initial public offering price, less the underwriting discounts and commissions, to cover over-allotments. The shares are expected to trade on The Nasdaq Global Market under the ticker symbol “ALZH.”\nCitigroup Global Markets Inc. and Piper Jaffray & Co. are acting as joint book-running managers for the offering. Canaccord Genuity LLC and JMP Securities LLC are acting as co-managers for the offering.\nThe offering is being made only by means of a prospectus. A copy of the preliminary prospectus related to the offering may be obtained from Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at (800) 831-9146; or Piper Jaffray & Co., 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, Attention: Prospectus Department, by telephone at (800) 747-3924 or by email at prospectus@pjc.com .\nA registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy these securities be accepted prior to the time that the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.\nForward-Looking Statements\nThis press release contains certain forward-looking statements, including statements with regard to Alzheon’s proposed securities offering. Words such as “believes,” “intends,” “expects,” “projects,” “anticipates,” and “future” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions and no assurance can be given that the proposed securities offering discussed above will be consummated on the terms described or at all. Completion of the proposed securities offering and the terms thereof are subject to numerous factors, many of which are beyond the control of Alzheon, including, without limitation, market conditions, failure of customary closing conditions and the risk factors and other matters set forth in Alzheon’s filings with the Securities and Exchange Commission. Alzheon undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required by law.\nView source version on businesswire.com : https://www.businesswire.com/news/home/20180402005403/en/\nThe Yates Network\nBarbara Yates, 781-258-6153\nbarbara@theyatesnetwork.com\nSource: Alzheon, Inc.", "external_links": ["https://www.businesswire.com/news/home/20180402005403/en/", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.alzheon.com%2F&esheet=51781666&newsitemid=20180402005403&lan=en-US&anchor=Alzheon%2C+Inc.&index=1&md5=54525b85dbd9530756445eced7c8f9ee"], "published": "2018-04-02T15:30:00.000+03:00", "crawled": "2018-04-02T19:00:47.026+03:00", "highlightTitle": ""}